Best Transurethral needle ablation (TUNA) Doctors Worldwide — TOP 18

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Mustafa Solak specializes in treating various cancers, including breast, testicular, and ovarian cancers, with a fellowship from Hacettepe University Cancer Institute.

• Completed residency at Istanbul Sisli Etfal Teaching and Research Hospital
• Fellowship-trained at Hacettepe University Cancer Institute
• Worked at The University of Texas MD Anderson Cancer Center
• Experienced in treating lung and gastrointestinal cancers

Head of Neurooncology Clinic at Ichilov – Dr. Bokstein brings specialized expertise to complex cases.

• Leads a dedicated neurooncology team
• Focuses on advanced treatment protocols
• Works at Sourasky Medical Center – a leading institution

Dr. Alemdar specializes in medical oncology with extensive training at Akdeniz University, one of Turkey's leading medical institutions.

• Board-certified in internal medicine and medical oncology
• Over 20 years of experience of experience in various hospitals across Turkey
• Member of the Turkish Medical Association

Specializes in genitourinary cancers with expertise in metronomic therapy – offers innovative treatments for complex cases.

• Trained in medical oncology at Tata Memorial Hospital, Mumbai
• Certified by ASCO, ESMO, and other prestigious oncological societies
• Presented lung cancer research at the World Conference on Lung Cancer

Dr. Borde brings 11 years of experience of nuclear medicine expertise with over 30,000 PET scans performed.

• Proficiency in all types of nuclear scans and PET-CT imaging
• Highly experienced in radioiodine & Lu-177 RN therapies
• Treated more than 1000 thyroid cancer patients
• Published author in various medical journals

Specializes in precise radiotherapy techniques including transurethral needle ablation (TUNA) at HCG Manavata Cancer Centre.

• Trained in radiotherapy at Banaras Hindu University
• Board-certified in radiotherapy by the National Board of Examination
• Member of the Association of Radiation Oncology of India and the Society for Neuro-Oncology

Dr. Ahmer Arif Shaikh specializes in surgical oncology with a focus on oral cancer and functional rehabilitation at HCG Manavata Cancer Centre.

• 15 years of experience of experience in surgical oncology
• Expertise in organ preservation and functional rehabilitation
• Fellowship-trained in Head & Neck Surgical Oncology
• Proficient in major maxillofacial surgeries
• Published researcher in the field

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.

Dr. Shaunak Valame specializes in targeted therapies with a strong academic background, including research presentations at international oncology symposiums.

• Completed DNB in Medical Oncology at Indraprastha Apollo Hospital
• Presented research on Stomach Cancer at ASCO's Gastrointestinal Cancer Symposium
• Interest in the molecular basis of cancer and targeted therapies
• Senior Residency in Internal Medicine with teaching experience

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.

30 years of experience of surgical oncology experience – Dr. Raj has performed 50,000+ cancer surgeries at HCG Manavata Cancer Centre.

• Trained at Tata Memorial Hospital and Royal College of Surgeons
• Specializes in breast and thoracic surgical oncology
• Professor for DNB Superspecialty Surgical Oncology
• Involved in 200+ clinical trials